In a groundbreaking development, our team at SYNG Pharma and a team of researchers at Collège La Cité are spearheading the creation of a rapid detection kit for endometriosis. The project, recently featured in an article in Capital Current, sheds light on the potential breakthrough in early diagnosis that could significantly impact the lives of countless individuals affected by this often debilitating condition.
The impact of an endometriosis rapid detection kit extends beyond the realm of medical research. It holds the potential to revolutionize women's health by offering a non-invasive and efficient means of diagnosing endometriosis. This could empower individuals to seek early medical attention, ultimately improving their overall well-being.
Read full article here: https://capitalcurrent.ca/an-endometriosis-rapid-detection-kit-under-study-by-college-la-cite-could-facilitate-early-diagnosis/?utm_source=dlvr.it&utm_medium=twitter&utm_campaign=an-endometriosis-rapid-detection-kit-under-study-by-college-la-cite-could-facilitate-early-diagnosis#